Select Medical Holdings Corporation maintained earnings guidance for the year ending December 31, 2023. For the year, the company expected revenue to be in the range of $6.55 billion to $6.7 billion and fully diluted earnings per share to be in the range of $1.77 to $1.94.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.08 USD | -0.41% |
|
+0.74% | +45.02% |
May. 06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
May. 06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.02% | 4.43B | |
+25.85% | 89.22B | |
-22.73% | 76.59B | |
+3.24% | 26.87B | |
-9.15% | 17.41B | |
+0.71% | 17.25B | |
-0.42% | 15.25B | |
+81.96% | 13.43B | |
+72.40% | 13.26B | |
-24.91% | 13.22B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Holdings Corporation Maintains Earnings Guidance for the Year Ending December 31, 2023